首页 > 最新文献

Porto biomedical journal最新文献

英文 中文
Medical therapeutics with an ecological concern. 关注生态的医学疗法。
Pub Date : 2024-06-19 eCollection Date: 2024-05-01 DOI: 10.1097/j.pbj.0000000000000255
José Pedro L Nunes
{"title":"Medical therapeutics with an ecological concern.","authors":"José Pedro L Nunes","doi":"10.1097/j.pbj.0000000000000255","DOIUrl":"10.1097/j.pbj.0000000000000255","url":null,"abstract":"","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"9 3","pages":"255"},"PeriodicalIF":0.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and neutrophil-lymphocyte-to-platelet ratio biomarkers in predicting bacteremia and sepsis in immunosuppressive patients with cancer: literature review. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值以及中性粒细胞-淋巴细胞-血小板比值生物标志物在预测免疫抑制性癌症患者菌血症和败血症方面的诊断准确性:文献综述。
Pub Date : 2024-06-04 eCollection Date: 2024-05-01 DOI: 10.1097/j.pbj.0000000000000254
Jose Manuel Martinez, Ana Espírito Santo, Diana Ramada, Filipa Fontes, Rui Medeiros

Background: This literature review explores the role of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and neutrophil-lymphocyte-to-platelet ratio (NLPR) biomarkers, as potential indicators for predicting bacteremia and sepsis in patients with cancer.

Objective: Tracing the evolution of interest in this area since 2001, the aim of this review was to report a comprehensive overview of current knowledge and gaps, particularly in patients undergoing immunosuppression.

Summary of findings: The literature research indicates the potential of NLR, PLR, and other biomarkers in diagnosing and predicting sepsis, with some studies emphasizing their value in mortality prediction. A specific focus on bacteremia shows the effectiveness of NLR and PLR as early indicators and prognostic tools, though mostly in noncancer patient populations. While NLR and PLR are promising in general cancer patient populations, the review addresses the challenges in applying these biomarkers to patients with neutropenic and lymphopenic cancer. The NLPR could be considered a significant biomarker for inflammation and mortality risk in various medical conditions, yet its diagnostic accuracy in patients with immunosuppressed cancer is not extensively validated.

Conclusion: This review offers a snapshot of the current research on biomarkers in patients with immunocompromised cancer in the sepsis and bacteremia area. More focused research on their application is necessary. This gap underscores an opportunity for future studies to enhance diagnostic and prognostic capabilities in this high-risk group.

背景:这篇文献综述探讨了中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和中性粒细胞-淋巴细胞-血小板比值(NLPR)生物标志物作为预测癌症患者菌血症和败血症的潜在指标的作用:本综述追溯了自 2001 年以来人们对这一领域兴趣的演变,旨在全面概述当前的知识和差距,特别是在接受免疫抑制的患者中:文献研究表明,NLR、PLR 和其他生物标志物在诊断和预测败血症方面具有潜力,一些研究强调了它们在预测死亡率方面的价值。对菌血症的特别关注显示了 NLR 和 PLR 作为早期指标和预后工具的有效性,尽管主要是在非癌症患者群体中。虽然 NLR 和 PLR 在普通癌症患者群体中很有前景,但本综述探讨了将这些生物标记物应用于中性粒细胞增多症和淋巴细胞增多症癌症患者所面临的挑战。NLPR可被视为各种疾病中炎症和死亡风险的重要生物标志物,但其在免疫抑制癌症患者中的诊断准确性尚未得到广泛验证:本综述概述了目前在脓毒症和菌血症领域对免疫受损癌症患者的生物标志物的研究。有必要对其应用进行更有针对性的研究。这一空白为今后的研究提供了机会,以提高这一高风险群体的诊断和预后能力。
{"title":"Diagnostic accuracy of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and neutrophil-lymphocyte-to-platelet ratio biomarkers in predicting bacteremia and sepsis in immunosuppressive patients with cancer: literature review.","authors":"Jose Manuel Martinez, Ana Espírito Santo, Diana Ramada, Filipa Fontes, Rui Medeiros","doi":"10.1097/j.pbj.0000000000000254","DOIUrl":"10.1097/j.pbj.0000000000000254","url":null,"abstract":"<p><strong>Background: </strong>This literature review explores the role of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and neutrophil-lymphocyte-to-platelet ratio (NLPR) biomarkers, as potential indicators for predicting bacteremia and sepsis in patients with cancer.</p><p><strong>Objective: </strong>Tracing the evolution of interest in this area since 2001, the aim of this review was to report a comprehensive overview of current knowledge and gaps, particularly in patients undergoing immunosuppression.</p><p><strong>Summary of findings: </strong>The literature research indicates the potential of NLR, PLR, and other biomarkers in diagnosing and predicting sepsis, with some studies emphasizing their value in mortality prediction. A specific focus on bacteremia shows the effectiveness of NLR and PLR as early indicators and prognostic tools, though mostly in noncancer patient populations. While NLR and PLR are promising in general cancer patient populations, the review addresses the challenges in applying these biomarkers to patients with neutropenic and lymphopenic cancer. The NLPR could be considered a significant biomarker for inflammation and mortality risk in various medical conditions, yet its diagnostic accuracy in patients with immunosuppressed cancer is not extensively validated.</p><p><strong>Conclusion: </strong>This review offers a snapshot of the current research on biomarkers in patients with immunocompromised cancer in the sepsis and bacteremia area. More focused research on their application is necessary. This gap underscores an opportunity for future studies to enhance diagnostic and prognostic capabilities in this high-risk group.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"9 3","pages":"254"},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11146520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141249229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-dementia drugs: what is the evidence in advanced stages? 抗痴呆药物:晚期的证据是什么?
Pub Date : 2024-04-29 eCollection Date: 2024-03-01 DOI: 10.1097/j.pbj.0000000000000251
Daniel Ferreira, Noémi Nogueira, Joana Guimarães, Rui Araújo

Dementia is a major public health concern due to its increasing prevalence, substantial caregiver burden, and high financial costs. Currently, the anti-dementia drugs aim only at a symptomatic effect. The subject of prescribing these drugs in advanced stages is a matter of considerable debate, with different countries making distinct recommendations. In this review article, we analyzed the evidence regarding cognitive and functional outcomes, adverse events, health-related costs, and caregiver burden in patients with advanced Alzheimer disease (AD) and mixed dementia. We included 35 studies. Most studies are heterogeneous, focus exclusively on AD, and show small benefits in terms of cognitive and functional scales. The overall evidence seems to suggest a benefit in introducing or maintaining anti-dementia drugs in patients with advanced dementia, but clinical meaningfulness is difficult to ascertain. The issue of costs and caregiver burden is significantly underexplored in this field but also seems to favor treatment continuation, despite a reduced overall effect. The decision of introducing or withdrawing anti-dementia drugs in advanced stages of dementia should be individualized. Future studies with homogeneous designs and outcomes are warranted.

痴呆症的发病率不断上升,给护理人员带来沉重负担,并造成高昂的经济成本,因此是一个重大的公共卫生问题。目前,抗痴呆药物的目的只是对症下药。关于在晚期患者中处方这些药物的问题,不同的国家提出了不同的建议,引起了广泛的争论。在这篇综述文章中,我们分析了晚期阿尔茨海默病(AD)和混合型痴呆患者的认知和功能结果、不良事件、健康相关成本和护理负担等方面的证据。我们纳入了 35 项研究。大多数研究都不尽相同,只关注阿尔茨海默病,并且在认知和功能量表方面显示出很小的益处。总体证据似乎表明,在晚期痴呆症患者中引入或维持抗痴呆药物有一定益处,但临床意义难以确定。成本和护理人员负担问题在这一领域的研究明显不足,但似乎也有利于继续治疗,尽管总体效果有所降低。在痴呆症晚期阶段使用或停用抗痴呆药物的决定应该因人而异。未来有必要开展设计和结果均一的研究。
{"title":"Anti-dementia drugs: what is the evidence in advanced stages?","authors":"Daniel Ferreira, Noémi Nogueira, Joana Guimarães, Rui Araújo","doi":"10.1097/j.pbj.0000000000000251","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000251","url":null,"abstract":"<p><p>Dementia is a major public health concern due to its increasing prevalence, substantial caregiver burden, and high financial costs. Currently, the anti-dementia drugs aim only at a symptomatic effect. The subject of prescribing these drugs in advanced stages is a matter of considerable debate, with different countries making distinct recommendations. In this review article, we analyzed the evidence regarding cognitive and functional outcomes, adverse events, health-related costs, and caregiver burden in patients with advanced Alzheimer disease (AD) and mixed dementia. We included 35 studies. Most studies are heterogeneous, focus exclusively on AD, and show small benefits in terms of cognitive and functional scales. The overall evidence seems to suggest a benefit in introducing or maintaining anti-dementia drugs in patients with advanced dementia, but clinical meaningfulness is difficult to ascertain. The issue of costs and caregiver burden is significantly underexplored in this field but also seems to favor treatment continuation, despite a reduced overall effect. The decision of introducing or withdrawing anti-dementia drugs in advanced stages of dementia should be individualized. Future studies with homogeneous designs and outcomes are warranted.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"9 2","pages":"251"},"PeriodicalIF":0.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11060217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early feeding and nutritional status of Portuguese children in the first 36 months of life: EPACI Portugal 2012-a national representative cross-sectional study. 葡萄牙儿童出生后前 36 个月的早期喂养和营养状况:2012 年葡萄牙 EPACI--一项具有全国代表性的横断面研究。
Pub Date : 2024-04-26 eCollection Date: 2024-03-01 DOI: 10.1097/j.pbj.0000000000000250
Margarida Nazareth, Elisabete Pinto, Milton Severo, Pedro Graça, Carla Lopes, Carla Rêgo

Background: Early feeding practices have a critical role in the future not only in health but also in modulating eating habits. This study aimed to assess breastfeeding and complementary feeding practices and the nutritional status of Portuguese toddlers aged 0-36 months.

Methods: EPACI Portugal 2012 is a cross-sectional study of a national representative sample. Trained interviewers collected data about early feeding practices and anthropometrics. Body mass index was classified according to World Health Organization criteria. Frequencies and survival analysis were used to characterize variables.

Results: More than 90% of children were initiated breastfeeding, around 20% were exclusively breastfed for six months, and about 20% were breastfed at 12 months while complementary feeding was taking place. Exclusive breastfeeding was determined by maternal prepregnancy body mass index (HR 1.01; 95% CI 1.00, 1.03, P=.03) and low birth weight (HR 1.61; IC 95% 1.21, 2.15, P=.001) of the infants. About 90% were initiated complementary feeding between four and six months, and almost 10% were introduced to cow's milk before 12 months. In the second year of life, 83.2% and 61.6% of toddlers have already consumed nectars and sweet desserts, respectively. About one-third of Portuguese toddlers showed a body mass index z-score >1, and 6.6% were overweight/obese (z-score >2). No association was found between the duration of breastfeeding or timing of complementary feeding and the body mass index z-score in children.

Conclusions: Despite the low prevalence of exclusive breastfeeding at six months, Portuguese infants effectively comply with dietary recommendations during the first year of life. The transition to the family diet must be carefully made. There is a high prevalence of Portuguese toddlers at least at overweight risk. The duration of breastfeeding or timing of complementary feeding was not associated with the expression of overweight/obesity.

背景:早期喂养方式不仅对未来的健康,而且对饮食习惯的养成都有着至关重要的作用。本研究旨在评估母乳喂养和辅食喂养方式以及葡萄牙 0-36 个月幼儿的营养状况:2012年葡萄牙EPACI是一项具有全国代表性的横断面研究。经过培训的访问员收集了有关早期喂养方式和人体测量的数据。体重指数根据世界卫生组织的标准进行分类。研究采用频率和生存分析来描述变量的特征:结果:90%以上的儿童开始进行母乳喂养,约20%的儿童纯母乳喂养6个月,约20%的儿童在12个月时进行母乳喂养,同时添加辅食。母体孕前体重指数(HR 1.01;95% CI 1.00,1.03,P=.03)和婴儿低出生体重(HR 1.61;IC 95% 1.21,2.15,P=.001)决定了是否纯母乳喂养。约 90% 的婴儿在 4 到 6 个月时开始添加辅食,近 10% 的婴儿在 12 个月前开始喝牛奶。在出生后的第二年,分别有 83.2% 和 61.6% 的幼儿已经食用过花蜜和甜点。约三分之一的葡萄牙幼儿的体重指数 z 值大于 1,6.6% 超重/肥胖(z 值大于 2)。母乳喂养持续时间或添加辅食的时间与儿童体重指数 z 值之间没有关联:尽管 6 个月纯母乳喂养的比例较低,但葡萄牙婴儿在出生后第一年能有效遵守饮食建议。向家庭饮食过渡必须谨慎。葡萄牙幼儿至少有超重风险的比例很高。母乳喂养的持续时间或添加辅食的时间与超重/肥胖的表现无关。
{"title":"Early feeding and nutritional status of Portuguese children in the first 36 months of life: EPACI Portugal 2012-a national representative cross-sectional study.","authors":"Margarida Nazareth, Elisabete Pinto, Milton Severo, Pedro Graça, Carla Lopes, Carla Rêgo","doi":"10.1097/j.pbj.0000000000000250","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000250","url":null,"abstract":"<p><strong>Background: </strong>Early feeding practices have a critical role in the future not only in health but also in modulating eating habits. This study aimed to assess breastfeeding and complementary feeding practices and the nutritional status of Portuguese toddlers aged 0-36 months.</p><p><strong>Methods: </strong>EPACI Portugal 2012 is a cross-sectional study of a national representative sample. Trained interviewers collected data about early feeding practices and anthropometrics. Body mass index was classified according to World Health Organization criteria. Frequencies and survival analysis were used to characterize variables.</p><p><strong>Results: </strong>More than 90% of children were initiated breastfeeding, around 20% were exclusively breastfed for six months, and about 20% were breastfed at 12 months while complementary feeding was taking place. Exclusive breastfeeding was determined by maternal prepregnancy body mass index (HR 1.01; 95% CI 1.00, 1.03, <i>P</i>=.03) and low birth weight (HR 1.61; IC 95% 1.21, 2.15, <i>P</i>=.001) of the infants. About 90% were initiated complementary feeding between four and six months, and almost 10% were introduced to cow's milk before 12 months. In the second year of life, 83.2% and 61.6% of toddlers have already consumed nectars and sweet desserts, respectively. About one-third of Portuguese toddlers showed a body mass index z-score >1, and 6.6% were overweight/obese (z-score >2). No association was found between the duration of breastfeeding or timing of complementary feeding and the body mass index z-score in children.</p><p><strong>Conclusions: </strong>Despite the low prevalence of exclusive breastfeeding at six months, Portuguese infants effectively comply with dietary recommendations during the first year of life. The transition to the family diet must be carefully made. There is a high prevalence of Portuguese toddlers at least at overweight risk. The duration of breastfeeding or timing of complementary feeding was not associated with the expression of overweight/obesity.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"9 2","pages":"250"},"PeriodicalIF":0.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11049788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent infection of dengue virus with malaria parasites among outpatients attending healthcare facilities in Benin city, Nigeria. 尼日利亚贝宁市医疗机构门诊患者登革热病毒与疟原虫并发感染情况。
Pub Date : 2024-04-15 eCollection Date: 2024-03-01 DOI: 10.1097/j.pbj.0000000000000249
Joy Zitgwai Saidu, Rachel Obhade Okojie

Background: Dengue virus (DENV) and malaria parasites (MP) are among the common febrile diseases affecting the tropics and subtropics of the world. Both are mosquito-borne pathogens affecting humans and other animals.

Methods: Blood samples were collected from 280 consented out-patients attending the selected hospitals and were analyzed. Malaria parasites were detected using microscopy and Malaria Ag Pf/Pan Rapid Test Device. Dengue virus was detected by serology and heminested reverse transcriptase PCR (hnRT-PCR) to target the flavivirus polymerase (NS5) gene.

Results: Malaria parasites recorded a total positivity of 151 patients (53.9%) using microscopy, while DENV antibodies (DENV IgM and DENV IgG) were positive in 16 (5.7%) and 39 (13.9%) patients, respectively. There was a concurrent infection between MP/DENV IgM in 13 (4.6%) patients and MP/DENV IgG in 27 (9.6%) patients. Molecular identification revealed DENV serotype 2 in circulation.

Conclusion: This study documents molecular evidence of dengue virus coexisting with malaria parasites in the study population, hence the need for efficient surveillance and control system.

背景:登革热病毒(DENV)和疟原虫(MP)是影响世界热带和亚热带地区的常见发热疾病。这两种疾病都是由蚊子传播的病原体,影响人类和其他动物:方法:从选定医院的 280 名同意就诊的门诊病人身上采集血液样本并进行分析。使用显微镜和疟疾 Ag Pf/Pan 快速检测仪检测疟疾寄生虫。登革热病毒通过血清学和针对黄病毒聚合酶(NS5)基因的螯合反转录酶聚合酶链式反应(hnRT-PCR)进行检测:通过显微镜检查,151 名患者(53.9%)的疟原虫呈阳性,而 DENV 抗体(DENV IgM 和 DENV IgG)呈阳性的患者分别为 16 名(5.7%)和 39 名(13.9%)。13例(4.6%)患者的MP/DENV IgM和27例(9.6%)患者的MP/DENV IgG同时感染。分子鉴定显示,血液循环中的 DENV 血清型为 2:本研究提供了研究人群中登革病毒与疟原虫共存的分子证据,因此需要建立有效的监测和控制系统。
{"title":"Concurrent infection of dengue virus with malaria parasites among outpatients attending healthcare facilities in Benin city, Nigeria.","authors":"Joy Zitgwai Saidu, Rachel Obhade Okojie","doi":"10.1097/j.pbj.0000000000000249","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000249","url":null,"abstract":"<p><strong>Background: </strong>Dengue virus (DENV) and malaria parasites (MP) are among the common febrile diseases affecting the tropics and subtropics of the world. Both are mosquito-borne pathogens affecting humans and other animals.</p><p><strong>Methods: </strong>Blood samples were collected from 280 consented out-patients attending the selected hospitals and were analyzed. Malaria parasites were detected using microscopy and Malaria Ag Pf/Pan Rapid Test Device. Dengue virus was detected by serology and heminested reverse transcriptase PCR (hnRT-PCR) to target the flavivirus polymerase (NS5) gene.</p><p><strong>Results: </strong>Malaria parasites recorded a total positivity of 151 patients (53.9%) using microscopy, while DENV antibodies (DENV IgM and DENV IgG) were positive in 16 (5.7%) and 39 (13.9%) patients, respectively. There was a concurrent infection between MP/DENV IgM in 13 (4.6%) patients and MP/DENV IgG in 27 (9.6%) patients. Molecular identification revealed DENV serotype 2 in circulation.</p><p><strong>Conclusion: </strong>This study documents molecular evidence of dengue virus coexisting with malaria parasites in the study population, hence the need for efficient surveillance and control system.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"9 2","pages":"249"},"PeriodicalIF":0.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11013702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary thyroid lymphoma: a case of postoperative diagnosis in a patient with toxic multinodular goiter 原发性甲状腺淋巴瘤:一名毒性多结节性甲状腺肿患者的术后诊断病例
Pub Date : 2024-03-08 DOI: 10.1097/j.pbj.0000000000000246
Margarida Nunes Coelho, Filipe Cunha, Joana Isabel Almeida, Tatiana Santos, Isabel Marques
{"title":"Primary thyroid lymphoma: a case of postoperative diagnosis in a patient with toxic multinodular goiter","authors":"Margarida Nunes Coelho, Filipe Cunha, Joana Isabel Almeida, Tatiana Santos, Isabel Marques","doi":"10.1097/j.pbj.0000000000000246","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000246","url":null,"abstract":"","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140076954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic impact of thrombocytosis in gastric cancer—A retrospective study 胃癌患者血小板增多的预后影响--一项回顾性研究
Pub Date : 2024-03-08 DOI: 10.1097/j.pbj.0000000000000247
B. Castro, Catarina Costa, Daniel Martins, A. Amado, Mariana Santos, Susana Graça, Amélia Tavares, António Ferreira, F. Viveiros, Sílvio Vale, Manuel Oliveira
Abstract BACKGROUND: Solid tumors are a common cause of secondary thrombocytosis, which has been identified as a prognostic factor in various cancers. However, the impact of thrombocytosis on the prognosis of gastric cancer is not yet well defined. The aim of this study was to assess the prevalence and prognostic value of thrombocytosis in patients with gastric cancer. METHODS: This was a retrospective study of patients with gastric carcinoma treated surgically, with curative intent, in our hospital, Centro Hospitalar Vila Nova de Gaia/Espinho, between January 2009 and December 2019. Clinical files were consulted and clinicopathological characteristics were analyzed. RESULTS: In the present sample (n = 352), the prevalence of pretreatment thrombocytosis was 16.5%. Thrombocytosis was associated with more advanced T stage, greater number of metastatic nodes, and more frequent lymphatic and venous permeation. The presence of thrombocytosis had a negative impact on disease-free survival (hazard ratio [HR] 3.54, 95% confidence interval [CI] 2.35–5.33, P < .001) and overall survival (HR 4.45, 95% CI 2.95–6.71, P < .001). CONCLUSIONS: The presence of pretreatment thrombocytosis had a negative impact on overall survival and disease-free survival and thus could be used as an independent prognostic factor.
摘要 背景:实体瘤是继发性血小板增多的常见原因,已被确定为各种癌症的预后因素之一。然而,血小板增多对胃癌预后的影响尚未明确。本研究旨在评估血小板增多症在胃癌患者中的患病率和预后价值。方法:这是一项回顾性研究,研究对象是 2009 年 1 月至 2019 年 12 月期间在我院(Centro Hospitalar Vila Nova de Gaia/Espinho)接受手术治疗的胃癌患者。我们查阅了临床档案,分析了临床病理特征。结果:在本样本(n = 352)中,治疗前血小板增多的发生率为16.5%。血小板增多与更晚的 T 期、更多的转移结节以及更频繁的淋巴和静脉穿透有关。血小板增多对无病生存期(危险比[HR] 3.54,95% 置信区间[CI] 2.35-5.33,P < .001)和总生存期(HR 4.45,95% 置信区间[CI] 2.95-6.71,P < .001)有负面影响。结论:治疗前血小板增多对总生存率和无病生存率有负面影响,因此可作为一个独立的预后因素。
{"title":"Prognostic impact of thrombocytosis in gastric cancer—A retrospective study","authors":"B. Castro, Catarina Costa, Daniel Martins, A. Amado, Mariana Santos, Susana Graça, Amélia Tavares, António Ferreira, F. Viveiros, Sílvio Vale, Manuel Oliveira","doi":"10.1097/j.pbj.0000000000000247","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000247","url":null,"abstract":"Abstract BACKGROUND: Solid tumors are a common cause of secondary thrombocytosis, which has been identified as a prognostic factor in various cancers. However, the impact of thrombocytosis on the prognosis of gastric cancer is not yet well defined. The aim of this study was to assess the prevalence and prognostic value of thrombocytosis in patients with gastric cancer. METHODS: This was a retrospective study of patients with gastric carcinoma treated surgically, with curative intent, in our hospital, Centro Hospitalar Vila Nova de Gaia/Espinho, between January 2009 and December 2019. Clinical files were consulted and clinicopathological characteristics were analyzed. RESULTS: In the present sample (n = 352), the prevalence of pretreatment thrombocytosis was 16.5%. Thrombocytosis was associated with more advanced T stage, greater number of metastatic nodes, and more frequent lymphatic and venous permeation. The presence of thrombocytosis had a negative impact on disease-free survival (hazard ratio [HR] 3.54, 95% confidence interval [CI] 2.35–5.33, P < .001) and overall survival (HR 4.45, 95% CI 2.95–6.71, P < .001). CONCLUSIONS: The presence of pretreatment thrombocytosis had a negative impact on overall survival and disease-free survival and thus could be used as an independent prognostic factor.","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"45 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140076801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aggressiveness in systemic anticancer therapy at the end of life in an oncology center 肿瘤中心临终前全身抗癌治疗的积极性
Pub Date : 2024-03-08 DOI: 10.1097/j.pbj.0000000000000248
J. Ferraz-Gonçalves, Inês Silva, Patrícia Redondo, M. Luís
Introduction: An increasing aggressiveness in cancer treatment at the end of life (EoL) has been reported in several, but not all, countries. This study aimed to see how aggressive cancer treatment is at the EoL in an oncology center. Methods: Retrospective study of patients 18 years or older with a solid cancer diagnosis who died in 2017. The focus was systemic anticancer therapy (SACT), excluding hormonotherapy. Results: In 2017, 2024 patients with solid tumors died. Of those patients, 1262 (62%) were male, and the median age was 69 (range 19–97) years. The most frequent primary cancer was lung cancer, followed by colorectal and stomach cancers, and 740 (37%) patients had metastatic disease. The median interval between SACT and death was 61 days. Of the patients undergoing SACT, 216 (27%) did it in the last month of life, 174 (22%) between 8 and 30 days from death, and 42 (5%) in the last week. On multivariable analysis, head and neck, colorectal, breast, and melanoma primaries; age group (older than 65 years); and metastatic disease had statistical significance associated with SACT. Of these variables, only metastatic disease is more likely to undergo SACT. Conclusion: This study confirms the relatively frequent aggressiveness in cancer treatment at the EoL. Taking into consideration previously published data, it can be tentatively concluded that the use of SACT increased in the last month and the last week of life.
导言:据报道,一些国家(但并非所有国家)在生命末期(EoL)的癌症治疗越来越积极。本研究旨在了解一家肿瘤中心在生命末期对癌症治疗的积极程度。研究方法对 2017 年死亡的 18 岁或以上确诊为实体瘤的患者进行回顾性研究。重点是全身抗癌治疗(SACT),不包括激素治疗。研究结果2017年,共有2024名实体瘤患者死亡。其中,1262人(62%)为男性,中位年龄为69岁(19-97岁)。最常见的原发性癌症是肺癌,其次是结直肠癌和胃癌,740 名(37%)患者患有转移性疾病。SACT 与死亡之间的中位间隔为 61 天。在接受SACT的患者中,有216人(27%)是在生命的最后一个月接受的,174人(22%)是在距离死亡8至30天之间接受的,42人(5%)是在最后一周接受的。多变量分析显示,头颈部、结直肠、乳腺和黑色素瘤原发灶、年龄组(65 岁以上)和转移性疾病与 SACT 有统计学意义。在这些变量中,只有转移性疾病更有可能接受 SACT。结论:这项研究证实,在 EoL 治疗癌症时,积极性相对较高。考虑到之前公布的数据,可以初步断定,在生命的最后一个月和最后一周,SACT的使用率有所增加。
{"title":"Aggressiveness in systemic anticancer therapy at the end of life in an oncology center","authors":"J. Ferraz-Gonçalves, Inês Silva, Patrícia Redondo, M. Luís","doi":"10.1097/j.pbj.0000000000000248","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000248","url":null,"abstract":"Introduction: An increasing aggressiveness in cancer treatment at the end of life (EoL) has been reported in several, but not all, countries. This study aimed to see how aggressive cancer treatment is at the EoL in an oncology center. Methods: Retrospective study of patients 18 years or older with a solid cancer diagnosis who died in 2017. The focus was systemic anticancer therapy (SACT), excluding hormonotherapy. Results: In 2017, 2024 patients with solid tumors died. Of those patients, 1262 (62%) were male, and the median age was 69 (range 19–97) years. The most frequent primary cancer was lung cancer, followed by colorectal and stomach cancers, and 740 (37%) patients had metastatic disease. The median interval between SACT and death was 61 days. Of the patients undergoing SACT, 216 (27%) did it in the last month of life, 174 (22%) between 8 and 30 days from death, and 42 (5%) in the last week. On multivariable analysis, head and neck, colorectal, breast, and melanoma primaries; age group (older than 65 years); and metastatic disease had statistical significance associated with SACT. Of these variables, only metastatic disease is more likely to undergo SACT. Conclusion: This study confirms the relatively frequent aggressiveness in cancer treatment at the EoL. Taking into consideration previously published data, it can be tentatively concluded that the use of SACT increased in the last month and the last week of life.","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"51 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140077113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of syphilitic uveitis in a 61-year-old non-HIV woman 一名 61 岁非艾滋病毒感染者患梅毒性葡萄膜炎的罕见病例
Pub Date : 2024-01-19 DOI: 10.1097/j.pbj.0000000000000242
Rita Oliveira, Lídia Carvalho, Angélica Ramos, Maria João Cardoso, João Tiago Guimarães
{"title":"A rare case of syphilitic uveitis in a 61-year-old non-HIV woman","authors":"Rita Oliveira, Lídia Carvalho, Angélica Ramos, Maria João Cardoso, João Tiago Guimarães","doi":"10.1097/j.pbj.0000000000000242","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000242","url":null,"abstract":"","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139525440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with the malnutrition inflammation score (MIS) among hemodialysis patients in Dhaka city: a cross-sectional study in tertiary care hospitals. 与达卡市血液透析患者营养不良炎症评分(MIS)相关的因素:一项在三级医院进行的横断面研究。
Pub Date : 2024-01-12 eCollection Date: 2024-01-01 DOI: 10.1097/j.pbj.0000000000000243
Khanum Un Homaira Bint Harun, Mahbuba Kawser, Mohammad Hayatun Nabi, Dipak Kumar Mitra

Background: Chronic kidney disease (CKD) is a progressive disease that leads to end-stage renal disease (ESRD). Malnutrition increases the risk of mortality among patients with ESRD. This study aimed to determine malnutrition prevalence and associated factors among twice-weekly (n = 94/120) and thrice-weekly (n = 26/120) hemodialysis patients/HDP.

Method: A cross-sectional study was conducted at two tertiary-level public hospitals in Dhaka city using a consecutive sampling technique from April to June 2021. Nutritional status was assessed by Malnutrition Inflammation Score (MIS). Multivariable ordinal logistic regression was performed to determine which socioeconomic, clinical, anthropometric, biochemical, and dietary factors are associated with MIS.

Results: The prevalence of malnutrition was very high among HDP (severe 15.5%, mild/moderate 56.7%) with an average dialysis vintage of 28.7 months. Comorbidities (80.8%) and gastrointestinal symptoms/GIS (68.3%) were ubiquitous, and "dialysis frequencies" were not associated with MIS in bivariate analysis. Multivariable ordinal regression showed that anthropometric factors like mid-upper arm circumference/MUAC (adjusted odds ratio/AOR = 0.978), post-dialysis body mass index/BMI (AOR = 0.957), and biochemical parameters like albumin (AOR = 0.733) and TIBC/total iron binding capacity (AOR = 0.996) negatively (P < .05) associated with MIS. Moreover, having "no GIS" (AOR = 0.672, P < .001) was 33.0% less likely to be associated with MIS. Contrarily, as the month of dialysis increases, MIS increases by 22.0% (AOR = 1.22).

Conclusion: Significant associations of clinical, anthropometric, and biochemical characteristics with MIS indicate the importance of routine screening of the nutritional status of patients with CKD to improve health status and prevent protein-energy wasting. The MIS could be a simple, noninvasive tool for testing nutritional status in patients with CKD.

背景:慢性肾脏病(CKD)是一种进展性疾病,会导致终末期肾脏病(ESRD)。营养不良会增加 ESRD 患者的死亡风险。本研究旨在确定每周两次(n = 94/120)和每周三次(n = 26/120)血液透析患者/终末期肾病患者的营养不良发生率和相关因素:方法:2021 年 4 月至 6 月,在达卡市两家三级公立医院采用连续抽样技术进行了一项横断面研究。营养状况通过营养不良炎症评分(MIS)进行评估。为确定哪些社会经济、临床、人体测量、生化和饮食因素与营养不良炎症评分相关,进行了多变量序数逻辑回归:HDP患者营养不良的发生率非常高(重度15.5%,轻度/中度56.7%),平均透析时间为28.7个月。合并症(80.8%)和胃肠道症状/GIS(68.3%)无处不在,在双变量分析中,"透析频率 "与 MIS 无关。多变量序数回归显示,人体测量因素如中上臂围/MUAC(调整比值/AOR = 0.978)、透析后体重指数/BMI(AOR = 0.957)以及生化参数如白蛋白(AOR = 0.733)和TIBC/总铁结合能力(AOR = 0.996)与 MIS 呈负相关(P < .05)。此外,"无 GIS"(AOR = 0.672,P < .001)与 MIS 的相关性降低了 33.0%。相反,随着透析月份的增加,MIS 会增加 22.0% (AOR = 1.22):临床、人体测量和生化特征与 MIS 的显著相关性表明,对慢性肾脏病患者的营养状况进行常规筛查对于改善健康状况和预防蛋白质能量消耗非常重要。MIS可以作为一种简单、无创的工具来检测慢性肾脏病患者的营养状况。
{"title":"Factors associated with the malnutrition inflammation score (MIS) among hemodialysis patients in Dhaka city: a cross-sectional study in tertiary care hospitals.","authors":"Khanum Un Homaira Bint Harun, Mahbuba Kawser, Mohammad Hayatun Nabi, Dipak Kumar Mitra","doi":"10.1097/j.pbj.0000000000000243","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000243","url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD) is a progressive disease that leads to end-stage renal disease (ESRD). Malnutrition increases the risk of mortality among patients with ESRD. This study aimed to determine malnutrition prevalence and associated factors among twice-weekly (n = 94/120) and thrice-weekly (n = 26/120) hemodialysis patients/HDP.</p><p><strong>Method: </strong>A cross-sectional study was conducted at two tertiary-level public hospitals in Dhaka city using a consecutive sampling technique from April to June 2021. Nutritional status was assessed by Malnutrition Inflammation Score (MIS). Multivariable ordinal logistic regression was performed to determine which socioeconomic, clinical, anthropometric, biochemical, and dietary factors are associated with MIS.</p><p><strong>Results: </strong>The prevalence of malnutrition was very high among HDP (severe 15.5%, mild/moderate 56.7%) with an average dialysis vintage of 28.7 months. Comorbidities (80.8%) and gastrointestinal symptoms/GIS (68.3%) were ubiquitous, and \"dialysis frequencies\" were not associated with MIS in bivariate analysis. Multivariable ordinal regression showed that anthropometric factors like mid-upper arm circumference/MUAC (adjusted odds ratio/AOR = 0.978), post-dialysis body mass index/BMI (AOR = 0.957), and biochemical parameters like albumin (AOR = 0.733) and TIBC/total iron binding capacity (AOR = 0.996) negatively (<i>P</i> < .05) associated with MIS. Moreover, having \"no GIS\" (AOR = 0.672, <i>P</i> < .001) was 33.0% less likely to be associated with MIS. Contrarily, as the month of dialysis increases, MIS increases by 22.0% (AOR = 1.22).</p><p><strong>Conclusion: </strong>Significant associations of clinical, anthropometric, and biochemical characteristics with MIS indicate the importance of routine screening of the nutritional status of patients with CKD to improve health status and prevent protein-energy wasting. The MIS could be a simple, noninvasive tool for testing nutritional status in patients with CKD.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"9 1","pages":"243"},"PeriodicalIF":0.0,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10857676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Porto biomedical journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1